Total Payments
$263,946
2024 Payments
$46,359
Companies
11
Transactions
284
Medicare Patients
15,612
Medicare Billing
$752,311
Payment Breakdown by Category
Other$134,423 (50.9%)
Consulting$87,512 (33.2%)
Travel$34,725 (13.2%)
Food & Beverage$5,616 (2.1%)
Research$1,657 (0.6%)
Education$12.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $134,423 | 37 | 50.9% |
| Consulting Fee | $87,512 | 26 | 33.2% |
| Travel and Lodging | $34,725 | 111 | 13.2% |
| Food and Beverage | $5,616 | 104 | 2.1% |
| Unspecified | $1,657 | 2 | 0.6% |
| Education | $12.80 | 4 | 0.0% |
Payments by Type
General
$262,290
282 transactions
Research
$1,657
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $166,436 | 142 | $0 (2024) |
| Medtronic, Inc. | $52,847 | 99 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $34,819 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,439 | 4 | $0 (2024) |
| Recor Medical Inc | $3,785 | 9 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,079 | 2 | $0 (2024) |
| Celgene Corporation | $342.48 | 2 | $0 (2023) |
| Corcept Therapeutics | $115.14 | 1 | $0 (2024) |
| Abbott Laboratories | $43.74 | 1 | $0 (2018) |
| Ablative Solutions, Inc. | $37.49 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,359 | 71 | Medtronic, Inc. ($24,445) |
| 2023 | $120,179 | 116 | E.R. Squibb & Sons, L.L.C. ($73,704) |
| 2022 | $83,930 | 82 | E.R. Squibb & Sons, L.L.C. ($82,157) |
| 2021 | $13,435 | 14 | Medtronic, Inc. ($9,861) |
| 2018 | $43.74 | 1 | Abbott Laboratories ($43.74) |
All Payment Transactions
284 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 12/15/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $186.51 | General |
| 12/13/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $60.80 | General |
| 12/13/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $60.80 | General |
| 12/13/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $22.60 | General |
| 12/13/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $16.21 | General |
| 12/13/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $14.87 | General |
| 12/12/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $189.00 | General |
| 12/12/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $49.08 | General |
| 12/12/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $40.85 | General |
| 12/11/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $204.35 | General |
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $222.17 | General |
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | Cash or cash equivalent | $32.13 | General |
| 11/19/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $182.43 | General |
| Category: Endovascular | ||||||
| 11/17/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,395.00 | General |
| 11/16/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $28.57 | General |
| 11/15/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $172.08 | General |
| Category: Endovascular | ||||||
| 11/15/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $107.42 | General |
| Category: Endovascular | ||||||
| 11/13/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $146.34 | General |
| Category: Endovascular | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,790.00 | General |
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $115.14 | General |
| Category: Endocrinology | ||||||
| 10/25/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $184.81 | General |
| 10/25/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $34.25 | General |
| 10/23/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Endovascular | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM) | E.R. Squibb & Sons, L.L.C. | $877.47 | 1 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy | E.R. Squibb & Sons, L.L.C. | $779.12 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 4,517 | 4,911 | $808,373 | $188,355 |
| 2022 | 18 | 4,053 | 4,405 | $757,741 | $171,597 |
| 2021 | 21 | 3,655 | 4,095 | $795,150 | $199,624 |
| 2020 | 19 | 3,387 | 3,816 | $810,164 | $192,736 |
Total Patients
15,612
Total Services
17,227
Medicare Billing
$752,311
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 1,965 | 2,077 | $489,865 | $116,373 | 23.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 163 | 166 | $64,462 | $14,330 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 140 | 189 | $60,918 | $14,156 | 23.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 486 | 556 | $51,782 | $11,526 | 22.3% |
| 93314 | Interpretation and report of ultrasound of heart | Facility | 2023 | 93 | 98 | $28,610 | $7,272 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 42 | 42 | $19,593 | $4,555 | 23.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 659 | 733 | $19,620 | $4,326 | 22.0% |
| 93319 | 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | Facility | 2023 | 142 | 145 | $11,910 | $2,804 | 23.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 13 | 14 | $13,004 | $2,385 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 43 | 49 | $10,676 | $2,364 | 22.1% |
| 93790 | Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report | Facility | 2023 | 133 | 141 | $8,243 | $1,972 | 23.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 21 | 21 | $10,250 | $1,901 | 18.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 551 | 612 | $7,180 | $1,572 | 21.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 19 | 19 | $5,824 | $1,270 | 21.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 20 | 22 | $4,704 | $1,169 | 24.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 27 | 27 | $1,732 | $379.50 | 21.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 1,806 | 1,919 | $467,162 | $106,551 | 22.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 139 | 143 | $55,905 | $12,660 | 22.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 380 | 427 | $42,428 | $8,901 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 101 | 121 | $38,803 | $8,758 | 22.6% |
| 93314 | Interpretation and report of ultrasound of heart | Facility | 2022 | 94 | 96 | $27,822 | $6,978 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 45 | 45 | $19,734 | $4,550 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 68 | 75 | $16,266 | $3,835 | 23.6% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2022 | 551 | 615 | $17,613 | $3,643 | 20.7% |
| 93319 | 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | Facility | 2022 | 127 | 131 | $10,480 | $2,768 | 26.4% |
About Dr. Florian Rader, MD
Dr. Florian Rader, MD is a Cardiovascular Disease healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841408812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Florian Rader, MD has received a total of $263,946 in payments from pharmaceutical and medical device companies, with $46,359 received in 2024. These payments were reported across 284 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($134,423).
As a Medicare-enrolled provider, Rader has provided services to 15,612 Medicare beneficiaries, totaling 17,227 services with total Medicare billing of $752,311. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine
- Location West Hollywood, CA
- Active Since 05/21/2007
- Last Updated 05/01/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1841408812
Products in Payments
- CAMZYOS (Drug) $107,510
- APROCITENTAN $16,524
- QUVIVIQ (Drug) $12,800
- SYMPLICITY G3 (Device) $7,568
- Tryvio (Drug) $5,495
- PARADISE RENAL DENERVATION SYSTEM (Device) $3,785
- Korlym (Drug) $115.14
- Resolute (Device) $76.30
- AMPLATZER Occluders (Device) $43.74
- ONYX FRONTIER (Device) $12.10
- CoreValve Evolut (Device) $6.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in West Hollywood
Dr. Raj Makkar, M.d, M.D
Cardiovascular Disease — Payments: $159,335
Cardiovascular Disease $159,335
Dr. Hasanian Jilaihawi, M.d, M.D
Cardiovascular Disease — Payments: $64,710
Cardiovascular Disease $64,710
Siddharth Singh, Mbbs, MBBS
Cardiovascular Disease — Payments: $9,152
Cardiovascular Disease $9,152
Dr. Amita Dharawat, M.d, M.D
Cardiovascular Disease — Payments: $5,530
Cardiovascular Disease $5,530
Dr. Eugenio Cingolani, M.d, M.D
Cardiovascular Disease — Payments: $5,057
Cardiovascular Disease $5,057
Dr. Rose Tompkins, Md, MD
Cardiovascular Disease — Payments: $310.12
Cardiovascular Disease $310.12